Osteoactivin is a positive regulator of osteoblast differentiation and has been recently identified as a regulator of lipogenesis in WAT and was also found to exacerbate diet induced obesity and insulin resistance (31). Here, GPNMB is linked to obesity due to melanocortin 4 receptor deficiency.